Fig. 2From: The role of immune checkpoint inhibition in the treatment of ovarian cancerOngoing or planned phase 3 trials in ovarian cancer with immune checkpoint inhibitors. a NCT02718417: Javelin Ovarian 100. b ENGOT-ov29-GCIG: ATALANTE. c NCT02580058: Javelin Ovarian 200. d NRG-GY009Back to article page